Tag Archive for: Sweden

TIRmed Pharma secures 4,3m€ to advance immunomodulatory treatment options for atopic dermatitis into clinical development. Stockholm-based TIRmed Pharma has closed this funding round, led by Sciety and its investment network, Sciety Venture Partners. The capital shall support the company’s progress toward clinical development of its novel treatment for atopic dermatitis.

Picture: © Neogap Therapeutics

Swedish Neogap Therapeutics got a new Chief Medical Officer (CMO). Dr Hanjing Xie has recently started her new position at the Stockholm-based biotech company.

© Columbia University Mailman School of Public Health

The financing (around €19m) shall fully fund the commencement of a potentially pivotal/registrational Phase 2/3 study for KL1333 and its progression to the outcome of a key interim analysis.